Patterns of immunotherapy utilization for non-small cell lung cancer in Texas pre- and post-regulatory approval.

Olajumoke Adenike OlatejuZhen ZengMarjan ZakeriSujit S Sansgiry

Published in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2024)

Our findings suggest that patients' socioeconomic status hinders immunotherapy utilization for NSCLC in Texas. This emphasizes the need for state health policy reforms such as Medicaid expansion and tailored cancer care strategies.

Keyphrases

public health
end stage renal disease
healthcare
ejection fraction
small cell lung cancer
mental health
newly diagnosed
chronic kidney disease
peritoneal dialysis
patient reported outcomes
health information
risk assessment
patient reported
tyrosine kinase
brain metastases